Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.66 CNY -0.91%
Market Cap: 101.3B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Shanghai RAAS Blood Products Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai RAAS Blood Products Co Ltd
Revenue Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Revenue
ÂĄ8.3B
CAGR 3-Years
37%
CAGR 5-Years
31%
CAGR 10-Years
27%
Beigene Ltd
HKEX:6160
Revenue
ÂĄ17.4B
CAGR 3-Years
102%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
ÂĄ7.5B
CAGR 3-Years
16%
CAGR 5-Years
84%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
ÂĄ5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
ÂĄ46.7B
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
51%
Imeik Technology Development Co Ltd
SZSE:300896
Revenue
ÂĄ2.9B
CAGR 3-Years
59%
CAGR 5-Years
55%
CAGR 10-Years
N/A

See Also

What is Shanghai RAAS Blood Products Co Ltd's Revenue?
Revenue
8.3B CNY

Based on the financial report for Jun 30, 2024, Shanghai RAAS Blood Products Co Ltd's Revenue amounts to 8.3B CNY.

What is Shanghai RAAS Blood Products Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
27%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Shanghai RAAS Blood Products Co Ltd have been 37% over the past three years , 31% over the past five years , and 27% over the past ten years .

Back to Top